TIPE2 inhibits lung cancer growth attributing to promotion of apoptosis by regulating some apoptotic molecules expression

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Liu, Qing Qing ^a   Zhang, Feng Feng ^a   Wang, Fang ^d   Qiu, Jing Hua ^a   Luo, Chun Hua ^b   Zhu, Guo Yong ^c   Liu, Ying Fu ^a  

^a XIAMEN UNIVERSITY   (China)

^b The Traditional Chinese Medical Hospital of Xiamen   (China)

^c THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^d Nanyang Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; I KAPPA B ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; SIGNAL PEPTIDE; TIPE2 PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CANCER CELL LINE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA; UPREGULATION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; DEFICIENCY; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; XENOGRAFT;

MUS MUSCULUS;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SMALL CELL LUNG CARCINOMA; TUMOR SUPPRESSOR PROTEINS;

EID: 84929120485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126176     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90. doi: 10.3322/caac.20107 PMID: 21296855
2. Houwen L. State of the art:lung cancer in China. Ann Thorac Cardiovasc Surg. 2003; 9: 147-148. PMID: 12882182
3. Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007; 57: 253-260. PMID: 17451842
4. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008; 133: 415-426. doi: 10.1016/j.cell.2008.03.026 PMID: 18455983
5. Li D, Song L, Fan Y, Li X, Li Y, Chen J, et al. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol. 2009; 133: 422-427. doi: 10.1016/j.clim.2009.08.014 PMID: 19748832
6. Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, et al. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol. 2011; 48: 1203-1208. doi: 10.1016/j.molimm.2011.03.002 PMID: 21466895
7. Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang Y, et al. Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol. 2010; 47: 2435-2442. doi: 10.1016/j.molimm.2010.06.016 PMID: 20663561
8. Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, Ma C, et al. The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol. 2011; 48: 1209-1215. doi: 10.1016/j.molimm.2011.03.001 PMID: 21459448
9. Cui J, Zhang G, Hao C, Wang Y, Lou Y, Zhang W, et al. The expression of TIPE1 in murine tissues and human cell lines. Mol Immunol. 2011; 48: 1548-1555. doi: 10.1016/j.molimm.2011.04.023 PMID: 21600655
10. Dong QZ, Zhao Y, Liu Y, Wang Y, Zhang PX, Jiang GY, et al. Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Sci. 2010; 101: 1562-1569. doi: 10.1111/j.1349-7006.2010.01557.x PMID: 20398053
11. Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I, Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene. 2004; 23: 612-616. PMID: 14724590
12. Zhang X, Wang J, Fan C, Li H, Sun H, Gong S, et al. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol. 2009; 16: 89-90. doi: 10.1038/nsmb.1522 PMID: 19079267
13. Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S, et al. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell. 2012; 45: 610-618. doi: 10.1016/j.molcel.2012.01.006 PMID: 22326055
14. Li XM, Su JR, Yan SP, Cheng ZL, Yang TT, Zhu Q. A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8. Cancer Biomark. 2014; 14: 233-240. doi: 10.3233/CBM-140402 PMID: 24934366
15. Zhang Z, Qi H, Hou S, Jin X. TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues. Oncol Lett. 2013; 6: 571-575. PMID: 24137373
16. Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C, et al. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer. 2013; 12: 149. doi: 10.1186/1476-4598-12-149 PMID: 24274578
17. Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C, et al. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol. 2009; 217: 54-64. doi: 10.1002/path.2429 PMID: 18798225
18. Liu YF, Zhang PF, Li MY, Li QQ, Chen ZC. Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma. Clin Exp Metastasis. 2011; 28: 413-425. doi: 10.1007/s10585-011-9380-1 PMID: 21365324
19. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. 2004; 53: 153-159. PMID: 14749900
20. Fennell DA. Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin Cancer Res. 2005; 11: 2097-2105. PMID: 15788654
21. Patel S, Wang FH, Whiteside TL, Kasid U. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol. 1997; 33: 197-203. PMID: 9307729
22. Zhang C, Chakravarty D, Sakabe I, Mewani RR, Boudreau HE, Kumar D, et al. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 2006; 13: 947-955. PMID: 16455304
23. Huang HL, Hsieh MJ, Chien MH, Chen HY, Yang SF, Hsiao PC. Glabridin mediate caspases activation and induces apoptosis through JNK1/2 and p38 MAPK pathway in human promyelocytic leukemia cells. PLoS One. 2014; 9: e98943. doi: 10.1371/journal.pone.0098943 PMID: 24901249
24. Zhou Y, Zhao W, Xie G, Huang M, Hu M, Jiang X, et al. Induction of Nur77-dependent apoptotic pathway by a coumarin derivative through activation of JNK and p38 MAPK. Carcinogenesis. 2014; 35: 2660-2669. doi: 10.1093/carcin/bgu186 PMID: 25187486
25. Liu J, Wu N, Ma LN, Zhong JT, Liu G, Zheng LH, et al. p38 MAPK signaling mediates mitochondrial apoptosis in cancer cells induced by oleanolic acid. Asian Pac J Cancer Prev. 2014; 15: 4519-4525. PMID: 24969879
26. Lauring J, Park BH, Wolff AC. The phosphoinositide-3-kinase-Akt-mTOR pathway as a therapeutic target in breast cancer. J Natl Compr Canc Netw. 2013; 11: 670-678. PMID: 23744866